---
layout: post
title: "Prioritizing the Addition of Maximum Daily Exposure Information and Removing Dosage Form Information From the Inactive Ingredient Database; Establishment of a Public Docket; Request for Comments"
date: 2026-02-05 18:58:32 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-06031
original_published: 2022-03-22 00:00:00 +0000
significance: 8.00
---

# Prioritizing the Addition of Maximum Daily Exposure Information and Removing Dosage Form Information From the Inactive Ingredient Database; Establishment of a Public Docket; Request for Comments

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** March 22, 2022 00:00 UTC
**Document Number:** 2022-06031

## Summary

The Food and Drug Administration (FDA, we, or Agency) is announcing the establishment of a docket to solicit comments that will assist the Agency in determining how best to prioritize the addition of maximum daily exposure (MDE) information for inactive ingredients that do not currently include MDE information in the Center for Drug Evaluation and Research's Inactive Ingredient Database (IID) and whether to restructure the IID by removing dosage form information.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/03/22/2022-06031/prioritizing-the-addition-of-maximum-daily-exposure-information-and-removing-dosage-form-information)
- API: https://www.federalregister.gov/api/v1/documents/2022-06031

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
